Function of the protein EFF-1 in cell membrane fusion
Function of the protein EFF-1 in cell membrane fusion
批准号:
6841163
负责人:
WILLIAM A MOHLER
金额:
$28.88万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-01-01 至 2007-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
EXCEED THE SPACE PROVIDED. The long-term goal of this proposal is to understand the mechanisms by which cell membranes become fusion competent in normal animal development. The fusion of somatic cells to form syncytial tissues is an essential part of human development, and cell fusion is an ancient process, shared in evolution by all eukaryotic phyla. Yet the molecular mechanism of cell fusion is essentially unknown in all species. Finding the molecules that drive plasma membrane fusion is therefore a major priority in understanding human health. Our studies of the nematode C. elegans have uncovered EFF-1, the first cellular membrane protein in any species that is known to be completely required for and completely specific to the process of cell membrane fusion. EFF-1 is a novel type I membrane protein, with sequence motifs that suggest modes of action via direct interaction and/or processing of membrane lipids: a phospholipase A2 active site, and a potential virus-like amphipathic fusion peptide. The absence of functional EFF-1 in mutant cells blocks cell membrane fusion at the earliest step in the process. We propose to determine the molecular function of EFF-1 in membrane fusion, and to further dissect the full mechanism of cell fusion via the following lines of inquiry: 1. Map and test the functional domains of EFF-1 through directed mutation analysis and via assays of enzymatic activity. 2. Assess the role of EFF-1 within the dynamic structural context of a cell fusion event by imaging of labeled EFF-1 protein within the fusing cells of live embryos. 3. Identify other protein components of the cell fusion machinery through isolation of molecules that interact physically and genetically with EFF-1. This proposal is submitted in response to PAS-00-067 from NICHD: "Membrane properties: Exploration of sperm/microbe susceptibility", as it focuses on topics specifically targeted by the PA. The scientific impact of the proposed research is of general import, however. Our results will increase understanding of the molecular mechanism underlying developmental cell fusion, a crucial and under-explored component of animal reproduction, development, and health. PERFORMANCE SITE ========================================Section End===========================================
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
2009 Cell-Cell Fusion
-
批准号:7667076
-
项目类别:
-
资助金额:$0.9万
-
财政年份:2009
-
负责人:WILLIAM A MOHLER
-
依托单位:
Spinning Microlens Confocal Microscope
-
批准号:6735917
-
项目类别:
-
资助金额:$20.62万
-
财政年份:2004
-
负责人:WILLIAM A MOHLER
-
依托单位:
SPINNING MICROLENS CONFOCAL MICROSCOPE: CELL & MOLECULARBIOLOGY: PROTEIN
-
批准号:6973715
-
项目类别:
-
资助金额:$20.62万
-
财政年份:2004
-
负责人:WILLIAM A MOHLER
-
依托单位:
Function of the protein EFF-1 in cell membrane fusion
-
批准号:6692596
-
项目类别:
-
资助金额:$28.77万
-
财政年份:2003
-
负责人:WILLIAM A MOHLER
-
依托单位:
Function of the protein EFF-1 in cell membrane fusion
-
批准号:7002633
-
项目类别:
-
资助金额:$28.37万
-
财政年份:2003
-
负责人:WILLIAM A MOHLER
-
依托单位:
Function of the protein EFF-1 in cell membrane fusion
-
批准号:6554068
-
项目类别:
-
资助金额:$26.49万
-
财政年份:2003
-
负责人:WILLIAM A MOHLER
-
依托单位:
Function of the protein EFF-1 in cell membrane fusion
-
批准号:7150051
-
项目类别:
-
资助金额:$27.71万
-
财政年份:2003
-
负责人:WILLIAM A MOHLER
-
依托单位:
CELL/CELL FUSION IN CAENORHABDITIS ELEGANS
-
批准号:2608714
-
项目类别:
-
资助金额:$2.52万
-
财政年份:1997
-
负责人:WILLIAM A MOHLER
-
依托单位:
CELL/CELL FUSION IN CAENORHABDITIS ELEGANS
-
批准号:2173133
-
项目类别:
-
资助金额:$2.26万
-
财政年份:1996
-
负责人:WILLIAM A MOHLER
-
依托单位:
CELL/CELL FUSION IN CAENORHABDITIS ELEGANS
-
批准号:2838399
-
项目类别:
-
资助金额:$3.57万
-
财政年份:1996
-
负责人:WILLIAM A MOHLER
-
依托单位:
国内基金
海外基金
登录
查看更多内容
子宫内膜间质与巨噬细胞之间通过Protein S-MerTK-Apelin信号对
话促进子宫腺肌病蜕膜化缺陷的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:吕海宁
-
依托单位:
有翅与无翅蚜虫差异分泌唾液蛋白Cuticular protein在调控植物细胞壁免疫中的功能
-
批准号:32372636
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:郭慧娟
-
依托单位:
原发性开角型青光眼中SIPA1L1促进小梁网细胞外基质蛋白累积升高眼压的作用机制
-
批准号:82371054
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:郭涛
-
依托单位:
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
-
批准号:82370976
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:郑凌艳
-
依托单位:
G蛋白偶联受体GPR110调控Lp-PLA2抑制非酒精性脂肪性肝炎的作用及机制研究
-
批准号:82370865
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:黄哲
-
依托单位:
细胞周期蛋白依赖性激酶Cdk1介导卵母细胞第一极体重吸收致三倍体发生的调控机制研究
-
批准号:82371660
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:魏喆
-
依托单位:
转运蛋白RCP调控巨噬细胞脂肪酸氧化参与系统性红斑狼疮发病的机制研究
-
批准号:82371798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:叶俊娜
-
依托单位:
紧密连接蛋白PARD3下调介导黏膜上皮屏障破坏激活STAT3/SNAI2通路促进口腔白斑病形成及进展的机制研究
-
批准号:82370954
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:沈雪敏
-
依托单位:
新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
-
批准号:82370885
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨
-
依托单位:
蛋白精氨酸甲基化转移酶PRMT5调控PPARG促进巨噬细胞M2极化及其在肿瘤中作用的机制研究
-
批准号:82371738
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:郑英霞
-
依托单位: